Showing results (531-540 of 9,119) with videos related to

Sort By:
Pageof 912
Somatic Cell and Molecular Genetics|March 1, 1992
Gene dosage and Down's syndrome: metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinaseA Elson, Y Bernstein, H Degani, et al.
Chirality|September 19, 2002
Determination of the plasma levels of metyrapone and its enantiomeric metyrapol metabolites by direct plasma injection and multidimensional achiral-chiral chromatographyNeila M Cassiano, Quezia B Cass, Ana Luiza G Degani, et al.
International Journal of Obesity (2005)|July 10, 2025
Psychological determinants of exercise adherence in individuals with severe obesity awaiting bariatric surgery: what strategies can physical therapists adopt in prehabilitation programs? A scoping reviewAnanda Quaresma Nascimento, Darlan Laurício Matte, Diego Bessa Dantas, et al.
Endocrine-Related Cancer|April 29, 2009
Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-MycMaya Dadiani, Dalia Seger, Tamar Kreizman, et al.
Current HIV Research|June 13, 2019
Evaluation of Phytopolyphenols for their gp120-CD4 Binding Inhibitory Properties by In Silico Molecular Modelling & In Vitro Cell Line StudiesAmit Mirani, Harish Kundaikar, Shilpa Velhal, et al.
JAMA|September 18, 1997
Guidelines for managing domestic abuse when male and female partners are patients of the same physician. The Delphi Panel and the Consulting GroupL E Ferris, P G Norton, E V Dunn, et al.
Parasites & Vectors|December 24, 2024
Evaluation of novel recombinant antigen-based (NIE/SsIR) immunochromatographic rapid tests for Strongyloides stercoralis: an accuracy studySalvatore Scarso, Francesca Tamarozzi, Cristina Mazzi, et al.
The Cochrane Database of Systematic Reviews|October 20, 2005
Interventions to enhance medication adherenceR B Haynes, X Yao, A Degani, et al.
Antibiotics (Basel, Switzerland)|July 8, 2020
3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine N-acetyltransferase, in MycobacteriaNeha Agre, Nilesh Tawari, Arundhati Maitra, et al.
Glycoconjugate Journal|January 7, 2019
Insights into the effects of N-glycosylation on the characteristics of the VC1 domain of the human receptor for advanced glycation end products (RAGE) secreted by Pichia pastorisGenny Degani, Alberto Barbiroli, Paula Magnelli, et al.
Pageof 912